2．A Checklist of Important Points in Research Using JADER-Reference-Cited by-同舟云学术

2．A Checklist of Important Points in Research Using JADER

Published:2020-10-25 Issue:2 Volume:25 Page:64-73
ISSN:1342-0445
Container-title:Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
language:en
Short-container-title:Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku

Author:

SAKAI Takamasa¹

Affiliation:

1. Drug Informatics, Faculty of Pharmacy, Meijo University, Japan

Publisher

Japanese Society for Pharmacoepidemiology

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jjpe/25/2/25_25.64/_pdf

Reference13 articles.

1. 1) Paludetto MN, Olivier-Abbal P, Montastruc JL. Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France? Pharmacoepidemiol Drug Saf 2012；21：1289-94. doi：10.1002/pds.3333.

2. 4) European Medicines Agency. Guideline on good pharmacovigilance practices (GVP) Module Ⅸ （Rev.1). ［https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-module-ix-signal-management-rev-1_en.pdf (accessed 2020-8-30)]

3. 5) Food and Drug Administration. Guidance for Industry - Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment.［https://www.fda.gov/files/drugs/published/Good-Pharmacovigilance-Practices-and-Pharmacoepidemiologic-Assessment-March-2005.pdf (accessed 2020-8-30)]

4. 6) Schulz KF, Altman DG, Moher D；CONSORT Group. CONSORT 2010 statement：updated guidelines for reporting parallel group randomised trials. BMJ 2010；340：c332. doi：10.1136/bmj.c332.

5. 7) Vandenbroucke JP, von Elm E, Altman DG, et al. the STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology （STROBE）：explanation and elaboration. Int J Surg 2014；12：1500-24. doi：10.1016/j.ijsu.2014.07.014.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 医療ビッグデータ，AIを適切に活用するためのリテラシー;YAKUGAKU ZASSHI;2023-06-01